Nebius Drops 10%, CoreWeave Sinks 9% as Rising Credit
Nebius Group (NBIS) fell about 10% to $152.58 and CoreWeave (CRWV) dropped about 9% to $61.53 after credit-default swap (CDS) spreads rose for AI infrastructure borrowers. CoreWeave’s CDS implied a 50% five-year default probability and its Q1 2026 interest expense rose to $536 million with free cash flow of -$4.71 billion, according to its report.
How this was made
The 30-second read
Why it matters
Rising CDS spreads imply higher default risk, which can compress equity multiples and raise refinancing costs for levered operators. The article also uses SKYY’s relative performance as a real-time gauge of whether the stress is concentrated.
Market read
Traders get a same-day, credit-market read-through via CDS levels and an ETF-based gauge (SKYY) for whether the selloff is contained to leveraged AI infrastructure borrowers.
What to watch
The article emphasizes CDS-implied default probability but does not quantify liquidity, covenant terms, or near-term maturities; those details could change how quickly equity risk reprices into actual refinancing outcomes.
Background
The piece frames the selloff as driven by rising credit-default-swap costs for AI-infrastructure borrowers, not by company earnings.
Ticker impact
Nebius CDS implies a 50% five-year default probability, and NBIS is down 10% midday, with a 43% monthly slide.
Near-term downside bias if CDS spreads remain elevated into the close; stabilization depends on any financing headlines.
The article ties the move to CDS-implied default probability and highlights negative free cash flow and rising interest expense, which typically worsen equity risk premia.
CoreWeave CDS topped about 855 bps Tuesday, implying a 50% five-year default probability, and CRWV is down 9% midday.
Further multiple compression likely while CDS stays wide; any fresh financing announcement could reduce tail-risk pricing.
The text provides specific CDS levels, links them to default probability, and notes negative free cash flow and doubling interest expense, which are direct credit-to-equity transmission channels.
Oracle CDS is above 215 bps, up from about 145 late last year, and ORCL is down 2% as yields rise.
Limited but persistent downside risk if CDS and note yields continue trending higher; otherwise could mean-revert with broader rates.
The article frames Oracle as caught in the same downtrend rather than a primary issuer-specific catalyst, so the incremental news value is weaker.
NVIDIA is down 3% and its CDS is at a new high, with the selloff targeting leveraged AI infrastructure names.
Short-term volatility likely; stabilization may occur if CDS stops making new highs or if equity buyers absorb the risk repricing.
NVDA is mentioned as part of the broader CDS-driven move, but the article does not provide a new NVDA-specific credit event beyond CDS reaching new highs.
Market effects
Signals a credit-driven reset for leveraged AI infrastructure borrowers, potentially tightening financing assumptions across the buildout supply chain.
Primarily US credit and equity markets, with Treasury yield levels reinforcing the tighter-financing narrative.
Could influence global AI infrastructure funding sentiment where similar leverage and capex financing structures exist.
Counterpoint
The SKYY ETF holding green suggests the market may be over-discounting credit risk for a subset of highly levered names rather than the entire cloud/AI complex.
Key entities
- companyNebius Group
NASDAQ-listed AI cloud pure-play whose stock is down 10% midday and down 43% over the past month amid CDS-driven repricing.
- companyCoreWeave
NASDAQ-listed AI infrastructure provider whose CDS implies a 50% five-year default probability and whose shares are down 9% midday.
- companyOracle
Large non-financial borrower whose CDS and note yields are rising, with ORCL down 2% in the session.
- companyNVIDIA
AI hardware leader whose CDS is at a new high and whose shares are down 3% as credit stress broadens.
- ETFFirst Trust Cloud Computing ETF
SKYY is up 0.59% despite heavy weights in pressured names, suggesting pain may be concentrated in leveraged buildout firms.
